Minerva Neurosciences Inc (NERV)

Jun 12, 2025

Citadel Advisors LLC Makes New Investment in Kuke Music Holding Limited (NYSE:KUKE) - Defense World

Jun 12, 2025

Jun 12, 2025

Citadel Advisors LLC Purchases New Holdings in Jiuzi Holdings, Inc. (NASDAQ:JZXN) - Defense World

Jun 12, 2025

Jun 12, 2025

Minerva Neurosciences, Inc. (NASDAQ:NERV) Shares Bought by Citadel Advisors LLC - Defense World

Jun 12, 2025

Jun 10, 2025

Minerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges - TipRanks

Jun 10, 2025

Jun 04, 2025

Major Depressive Disorder Pipeline Appears Robust With 75+ Key Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jun 04, 2025

Jun 04, 2025

Minerva Neurosciences, Inc. (NASDAQ:NERV) Shares Bought by Northern Trust Corp - Defense World

Jun 04, 2025

May 23, 2025

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at Wall Street Zen - Defense World

May 23, 2025

May 14, 2025

Minerva Neurosciences: Q1 Earnings Snapshot - CT Insider

May 14, 2025

May 13, 2025

Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewswire

May 13, 2025

May 13, 2025

NERV's Cash Reserves Decrease by $4.1 Million in Q1 2025 | NERV Stock News - GuruFocus

May 13, 2025

May 13, 2025

Minerva Neurosciences Reports First Quarter 2025 Financial Resul - GuruFocus

May 13, 2025

May 13, 2025

MINERVA NEUROSCIENCES Earnings Results: $NERV Reports Quarterly Earnings - Nasdaq

May 13, 2025

May 13, 2025

Minerva Neurosciences, Inc. SEC 10-Q Report - TradingView

May 13, 2025

May 13, 2025

Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025

May 13, 2025

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated by Analysts at StockNews.com - Defense World

May 13, 2025

May 06, 2025

Minerva Neurosciences (NERV) Expected to Announce Quarterly Earnings on Wednesday - Defense World

May 06, 2025

May 06, 2025

Renaissance Technologies LLC Has $285,000 Stock Holdings in Minerva Neurosciences, Inc. (NASDAQ:NERV) - Defense World

May 06, 2025

May 05, 2025

Minerva Neurosciences (NASDAQ:NERV) Now Covered by Analysts at StockNews.com - Defense World

May 05, 2025

May 01, 2025

Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight - GlobeNewswire Inc.

May 01, 2025

May 01, 2025

Schizophrenia Market to Witness Significant Growth by 2034 - GlobeNewswire

May 01, 2025

Apr 27, 2025

StockNews.com Initiates Coverage on Minerva Neurosciences (NASDAQ:NERV) - Defense World

Apr 27, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 19, 2025

Minerva Neurosciences (NASDAQ:NERV) Share Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World

Apr 19, 2025

Apr 19, 2025

Minerva Neurosciences (NASDAQ:NERV) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 19, 2025

Apr 14, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 14, 2025

Apr 13, 2025

StockNews.com Begins Coverage on Minerva Neurosciences (NASDAQ:NERV) - The AM Reporter

Apr 13, 2025

Apr 10, 2025

CLASS ACTION UPDATE for TILE, NERV and QSR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire

Apr 10, 2025

Apr 09, 2025

CLASS ACTION UPDATE for BABA, NAK and NERV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire

Apr 09, 2025

Apr 08, 2025

Parkinson's Disease Pipeline Analysis and Clinical Trials - openPR.com

Apr 08, 2025

Apr 04, 2025

Minerva Neurosciences stock hits 52-week low at $1.29 - Investing.com Australia

Apr 04, 2025

Apr 04, 2025

Minerva Neurosciences stock hits 52-week low at $1.29 By Investing.com - Investing.com South Africa

Apr 04, 2025

Mar 24, 2025

Major depressive disorder Drugs Market 2034: Clinical Trials, - openPR.com

Mar 24, 2025

Mar 20, 2025

Minerva Neurosciences regains Nasdaq compliance By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

Minerva Neurosciences regains Nasdaq compliance - Investing.com India

Mar 20, 2025

Mar 19, 2025

FINAL DEADLINE ALERT: ROSEN, LEADING AND RESPECTED INVESTOR COUNSEL, Encourages Minerva Neurosciences, Inc. Investors with Large Losses to Secure Counsel Before Important February 8 Deadline – NERV - Business Wire

Mar 19, 2025

Mar 13, 2025

Parkinson's Disease Clinical Pipeline | 130+ Companies Advancing the Future of Treatment - openPR

Mar 13, 2025

Mar 07, 2025

Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld MedTech

Mar 07, 2025

Mar 05, 2025

Minerva Neurosciences Reports Improved 2024 Financials - TipRanks

Mar 05, 2025

Mar 02, 2025

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at StockNews.com - Defense World

Mar 02, 2025